Cyclooxygenase in biology and disease

10.1038/newbio231232a0

Mead J. F., 1986, Lipids: Chemistry, Biochemistry, and Nutrition, 149, 10.1007/978-1-4613-2107-1_10

10.1016/0005-2760(95)00194-8

Herschman H. R., 1995, Inflammation, reproduction, cancer and all that…, The regulation and role of the inducible prostaglandin synthase. Bioessays, 17, 1031

10.1097/00002281-199605000-00001

Breyer M. D., 1996, Functional and molecular aspects of renal prostaglandin receptors, J. Am. Soc. Nephrol., 7, 8, 10.1681/ASN.V718

10.1111/j.1749-6632.1996.tb18621.x

10.1007/BF02049158

10.1146/annurev.pa.33.040193.002251

Raz A., 1988, Regulation of fibroblast cyclooxygenase synthesis by interleukin-1, J. Biol. Chem., 263, 3022, 10.1016/S0021-9258(18)69170-7

10.1016/S0090-6980(96)00089-5

10.1074/jbc.271.52.33157

10.1073/pnas.93.10.4816

10.1074/jbc.271.1.186

Williams C. S., 1996, Prostaglandin endoperoxide synthase: why two isoforms? Am, J. Physiol., 270, G393

10.1016/0014-5793(93)81653-H

Murakami M., 1994, Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells, J. Biol. Chem., 269, 22269, 10.1016/S0021-9258(17)31786-6

10.1016/S0005-2760(96)00131-2

10.1006/bbrc.1993.1483

Crofford L. J., 1997, COX-1 and COX-2 tissue expression: implications and predictions, J. Rheum., 24, 15

10.1002/j.1552-4604.1995.tb04050.x

Palmer B. F., 1995, Clinical acute renal failure with nonsteroidal anti-inflammatory drugs, Semin. Nephrol., 15, 214

Zambraski E. J., 1995, The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals, Semin. Nephrol., 15, 205

Trevethick M. A., 1995, Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: underlying pathological mechanisms, Gm. Pharmacol., 26, 1455

10.1053/gast.1997.v112.pm9041264

10.1016/S0049-0172(96)80024-2

10.1016/0002-9343(93)90396-7

10.1172/JCI117620

Guan Y., 1997, Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells, Am. J. Physiol., 273, F18

10.1097/00004872-199607000-00003

10.1172/JCI109487

10.1038/378406a0

10.1016/0092-8674(95)90125-6

Cao C., 1997, Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain, Am.J. Physiol., 272, R1712

10.1111/j.1749-6632.1997.tb51709.x

10.1016/S0014-2999(97)00183-0

10.1111/j.1749-6632.1997.tb51710.x

10.1111/j.1432-1033.1997.00726.x

10.1016/S0387-7604(96)00047-2

10.1016/0896-6273(93)90192-T

10.1073/pnas.93.6.2317

10.1006/exnr.1997.6429

10.1073/pnas.94.12.6500

10.1016/S0889-8553(05)70247-8

Roth S. H., 1996, NSAID gastropathy. A new understanding, Arch. Int. Med., 156, 1623, 10.1001/archinte.1996.00440140039003

10.1172/JCI119296

10.1172/JCI119535

10.1097/00002281-199705000-00002

10.1172/JCI107201

10.1016/S0095-5108(18)30265-3

Zuckerman H., 1974, Inhibition of human premature labor by indomethacin, Obstet. Gynecol., 44, 787

10.1016/S0095-5108(18)30293-8

Richards J. S., 1995, Ovarian cell differentiation: a cascade of multiple hormones, cellular signals, and regulated genes, Rec. Prog. Hormone Res., 50, 223

10.1210/edrv-15-6-725

10.1007/978-1-4899-0952-7_8

10.1210/en.137.6.2522

10.1210/en.138.9.3638

10.1074/jbc.271.28.16633

10.1677/jme.0.0160107

10.1095/biolreprod56.2.368

10.1210/en.138.11.4599

10.1016/S0092-8674(00)80402-X

10.1126/science.277.5326.681

Kawaguchi H., 1995, The role of prostaglandins in the regulation of bone metabolism, Clin. Orthop. Relat. Res., 313, 36

10.1002/jbmr.5650110909

10.1359/jbmr.1997.12.1.45

Pilbeam C. C., 1996, Principles of Bone Biology, 715

10.1359/jbmr.1997.12.8.1198

10.1111/j.1749-6632.1993.tb17165.x

10.1111/j.1749-6632.1993.tb17164.x

Sato T., 1995, Involvement of cyclooxygenase-2 in bone loss induced by interleukin-1β, Adv. Prostaglandin, Thromboxane, Leukotriene Res., 23, 445

10.1210/endo.138.6.5192

Onoe Y., 1996, IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts, J. Immunol., 156, 758, 10.4049/jimmunol.156.2.758

Tetradis S., 1997, Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3′, 5′-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells, Endocrinology, 138, 3594, 10.1210/endo.138.9.5391

10.1096/fasebj.11.6.9194530

10.1146/annurev.ph.41.030179.003221

Needleman P., 1997, The discovery and function of COX-2, J. Rheum., 24, 6

10.1172/JCI118717

10.1172/JCI119280

10.1093/rheumatology/35.8.711

10.1007/BF02259612

Penning T., 1997, Synthesis and biological evaluation of the 1, 5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib), J. Med. Chem., 440, 1347, 10.1021/jm960803q

Lipsky P. E., 1997, Outcome of specific COX-2 inhibition in rheumatoid arthritis, J. Rheum., 24, 9

10.1146/annurev.pa.36.040196.001345

10.1016/S0006-8993(96)00817-7

Cherng C. H., 1996, Spinal actions of nonsteroidal anti-inflammatory drugs, Acta Anaesthesiol. Sinica, 34, 81

10.2165/00003495-199549010-00005

10.2165/00003495-199600525-00004

10.1016/0014-5793(96)00604-7

10.1007/s000110050174

Lane N. E., 1997, Pain management in osteoarthritis: the role of COX-2 inhibitors, J. Rheum., 24, 20

10.1073/pnas.91.25.12013

10.1212/WNL.45.8.1441

10.1212/WNL.47.2.425

10.1212/WNL.48.3.626

10.1016/0197-4580(95)00049-K

10.1016/0197-4580(96)00109-1

10.1159/000213834

10.7326/0003-4819-121-4-199408150-00001

10.1056/NEJM199509073331001

10.1016/S1054-3589(08)60067-8

10.1056/NEJM199112053252301

Thun M. J., 1993, Aspirin use and risk of fatal cancer, Cancer Res., 53, 1322

10.1016/0959-8049(95)00137-8

10.1172/JCI119651

Kawamori T., 1998, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis, Cancer Res., 58, 409

10.1016/0016-5085(94)90246-1

Kargman S., 1995, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res., 55, 2556

Sano H., 1995, Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res., 55, 3785

10.1172/JCI119400

Sheng H., 1998, Modulation of apoptosis by prostaglandin treatment in human colon cancer cells, Cancer Res., 58, 362

10.1016/0092-8674(95)90127-2

10.1016/S0092-8674(00)81433-6

10.1016/S0092-8674(00)81988-1

Piazza G. A., 1995, Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis, Cancer Res., 55, 3110

Thompson H. J., 1997, Sulfone metabolite of sulindac inhibits mammary carcinogenesis, Cancer Res., 57, 267

10.1016/0006-2952(96)00181-5